Greaves R R, O'Donnell L J, Farthing M J
Digestive Disease Research Centre, St. Bartholomew's and the Royal London School of Medicine and Dentistry, UK.
Dig Dis Sci. 2000 Dec;45(12):2376-81. doi: 10.1023/a:1005624016268.
Nonsteroidal antiinflammatory drugs, inhibitors of prostaglandin synthesis, have different effects on gallbladder contractility in normal and diseased human gallbladders in vivo. We investigated this differential effect by comparing the effects of prostaglandins PGE2 and PGF2alpha, the thromboxane A2 mimetic U46619, and PGI2 on in vitro contractility in gallstone-free and gallstone-containing human gallbladders. Isometric tension was measured in gallbladder muscle strips mounted in organ baths. EC50 was calculated for each agonist. The rank order of potency in gallstone-free gallbladders was PGE2 > CCK > U46619 > PGF2alpha and in gallstone-containing gallbladders was U46619 > PGE2 > CCK > PGF2alpha. PGI2 produced contraction of gallstone-free gallbladder and relaxation of gallstone-containing gallbladder in the basal state. Further, PGI2 produced no relaxation in gallstone-free muscle strips precontracted with CCK, but significant relaxation in CCK precontracted gallstone-containing strips. PGE2, PGF2alpha, and U46619 are potent contractors of gallstone-free and gallstone-containing gallbladders, whereas PGI2 relaxes only gallstone-containing gallbladders. Since gallbladders containing cholesterol-supersaturated bile produce increased PGI2, this PGI2-induced relaxation may be a determinant of the impaired gallbladder motility of gallstone disease.
非甾体类抗炎药,即前列腺素合成抑制剂,在体内对正常和患病的人体胆囊收缩性具有不同影响。我们通过比较前列腺素PGE2和PGF2α、血栓素A2类似物U46619以及PGI2对无结石和有结石的人体胆囊体外收缩性的影响,来研究这种差异效应。在置于器官浴槽中的胆囊肌条上测量等长张力。计算每种激动剂的半数有效浓度(EC50)。在无结石胆囊中,效力的排序为PGE2 > 胆囊收缩素(CCK)> U46619 > PGF2α;在有结石胆囊中,效力排序为U46619 > PGE2 > CCK > PGF2α。在基础状态下,PGI2使无结石胆囊收缩,使有结石胆囊舒张。此外,PGI2对用CCK预收缩的无结石肌条无舒张作用,但对用CCK预收缩的有结石肌条有显著舒张作用。PGE2、PGF2α和U46619是无结石和有结石胆囊的强效收缩剂,而PGI2仅使有结石胆囊舒张。由于含有胆固醇过饱和胆汁的胆囊会产生更多的PGI2,这种PGI2诱导的舒张可能是胆结石疾病中胆囊运动功能受损的一个决定因素。